Nu Skin Enterprises (NYSE:NUS) Stock Rating Lowered by Wall Street Zen

Nu Skin Enterprises (NYSE:NUS) was downgraded by stock analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued on Saturday.

A number of other research analysts also recently issued reports on the company. Zacks Research raised Nu Skin Enterprises to a “hold” rating in a report on Tuesday, August 12th. Weiss Ratings reissued a “hold (c)” rating on shares of Nu Skin Enterprises in a research report on Saturday, September 27th. Four analysts have rated the stock with a Hold rating, According to MarketBeat.com, Nu Skin Enterprises has a consensus rating of “Hold” and a consensus target price of $6.88.

Nu Skin Enterprises Trading Down 3.0%

NYSE:NUS opened at $11.37 on Friday. The stock has a market cap of $562.79 million, a price-to-earnings ratio of 5.66 and a beta of 0.97. The company has a quick ratio of 1.38, a current ratio of 2.01 and a debt-to-equity ratio of 0.27. The company’s 50 day moving average price is $11.19 and its 200-day moving average price is $8.72. Nu Skin Enterprises has a 52 week low of $5.32 and a 52 week high of $14.62.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.18. Nu Skin Enterprises had a return on equity of 8.23% and a net margin of 6.20%.The business had revenue of $386.14 million for the quarter, compared to analysts’ expectations of $376.68 million. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. On average, equities research analysts forecast that Nu Skin Enterprises will post 1.05 earnings per share for the current fiscal year.

Insider Transactions at Nu Skin Enterprises

In other Nu Skin Enterprises news, Director Daniel W. Campbell sold 23,391 shares of the company’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $12.10, for a total transaction of $283,031.10. Following the completion of the sale, the director directly owned 53,375 shares of the company’s stock, valued at approximately $645,837.50. This represents a 30.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Laura Nathanson sold 6,489 shares of the stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $12.22, for a total transaction of $79,295.58. Following the completion of the transaction, the director owned 33,149 shares in the company, valued at $405,080.78. The trade was a 16.37% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 58,926 shares of company stock worth $711,364 in the last quarter. Company insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Nu Skin Enterprises

A number of institutional investors have recently bought and sold shares of NUS. GAMMA Investing LLC lifted its position in Nu Skin Enterprises by 63.5% during the third quarter. GAMMA Investing LLC now owns 3,036 shares of the company’s stock valued at $37,000 after purchasing an additional 1,179 shares in the last quarter. Tower Research Capital LLC TRC increased its position in Nu Skin Enterprises by 107.4% in the second quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company’s stock worth $40,000 after buying an additional 2,614 shares in the last quarter. Man Group plc raised its stake in shares of Nu Skin Enterprises by 209.6% in the second quarter. Man Group plc now owns 247,992 shares of the company’s stock worth $1,981,000 after buying an additional 167,902 shares during the period. BNP Paribas Financial Markets raised its stake in shares of Nu Skin Enterprises by 2.7% in the second quarter. BNP Paribas Financial Markets now owns 348,646 shares of the company’s stock worth $2,786,000 after buying an additional 9,052 shares during the period. Finally, Bridgeway Capital Management LLC lifted its position in shares of Nu Skin Enterprises by 330.2% during the 2nd quarter. Bridgeway Capital Management LLC now owns 215,124 shares of the company’s stock valued at $1,719,000 after buying an additional 165,124 shares in the last quarter. 82.84% of the stock is owned by institutional investors.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.